Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement Virginia A. Moyer, MD, PhD, on behalf of the U.S. Preventive Services Task Force* Description: Update of the 2008 U.S. Preventive Services Task

Force (USPSTF) recommendation statement on screening for pros-tate cancer. Methods: The USPSTF reviewed new evidence on the benefits and harms of prostate-specific antigen (PSA)–based screening for pros-tate cancer, as well as the benefits and harms of treatment of localized prostate cancer. Recommendation: The USPSTF recommends against PSA-based screening for prostate cancer (grade D recommendation). This recommendation applies to men in the general U.S. popu-lation, regardless of age. This recommendation does not include the use of the PSA test for surveillance after diagnosis or treatment of prostate cancer; the use of the PSA test for this indication is outside the scope of the USPSTF. Ann Intern Med. 2012;157:120-134. www.annals.or